Autopsy report · NCT05248685

Optimized Dual CD33/CLL1 CAR T Cells in Subjects With Refractory or Relapsed Acute Myeloid Leukemia

“no patients”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1

Sponsor

Beijing Boren Hospital

Sponsor type

University, hospital or other

Conditions

Acute Myeloid Leukemia

Interventions

Dual CD33/CLL1 CAR T

Participants

0

Sites

1

Countries

China

Trials that died the same way

• Hepatic Mitochondrial Function in Sepsis
  “no patients to include” (87% match in meaning)
• Exploration of the Enteric Nervous System in Alzheimer Disease
  “no patients included” (87% match in meaning)
• Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
  “No patients recruited” (82% match in meaning)
• Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis
  “no patients were included” (82% match in meaning)
• A2R and Ectonucleotidases Expression in Lung Cancer Circulating Tumor Cells
  “no patients enrolled” (81% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.